Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mack Roach

Showing results (231-240 of 284) with videos related to

Pageof 29
Sort By:
International Journal of Radiation Oncology, Biology, Physics|November 6, 2021
Salvage Low-Dose-Rate Prostate Brachytherapy: Clinical Outcomes of a Phase 2 Trial for Local Recurrence after External Beam Radiation Therapy (NRG Oncology/RTOG 0526)Juanita Crook, Joseph P Rodgers, Thomas M Pisansky, et al.
The Journal of Urology|November 12, 2003
Third international conference on innovations and challenges in prostate cancer: prevention, detection and treatmentPeter R Carroll, David A Benaron, George Blackledge, et al.
Neuro-Oncology Practice|December 14, 2019
The association between BMI and BSA-temozolomide-induced myelosuppression toxicities: a correlative analysis of NRG oncology RTOG 0525H Ian Robins, Jens Eickhoff, Mark R Gilbert, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 14, 2018
The American Brachytherapy Society and the American Radium Society Appropriate Use Criteria Genitourinary Committee Endorse the American Society of Clinical Oncology/Cancer Care Ontario GuidelinesAlbert J Chang, Sean McBride, Mira Keyes, et al.
World Journal of Urology|July 10, 2020
Clinical recommendations in the management of advanced prostate cancer: International Gastrointestinal, Liver and Uro-oncology (IGILUC 2019) expertsHesham Elghazaly, Nicolas Mottet, Jorge Garcia, et al.
Cancers|June 26, 2026
A Multimodal Artificial Intelligence Model to Guide Use of Whole-Pelvic Radiation Therapy in Patients with Localized Prostate Cancer: Exploratory Analysis of RTOG 9413Mutlay Sayan, Huei-Chung Huang, Erin L Stewart, et al.
European Urology Oncology|March 3, 2023
Development and External Validation of a Machine Learning Model for Prediction of Lymph Node Metastasis in Patients with Prostate CancerAli Sabbagh, Samuel L Washington, Derya Tilki, et al.
International Journal of Radiation Oncology, Biology, Physics|May 3, 2017
Duration of Androgen Deprivation in Locally Advanced Prostate Cancer: Long-Term Update of NRG Oncology RTOG 9202Colleen A F Lawton, Xiaolei Lin, Gerald E Hanks, et al.
BJU International|January 14, 2012
Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study GroupPeter Grimm, Ignace Billiet, David Bostwick, et al.
International Journal of Radiation Oncology, Biology, Physics|April 9, 2019
Prostate-Specific Antigen After Neoadjuvant Androgen Suppression in Prostate Cancer Patients Receiving Short-Term Androgen Suppression and External Beam Radiation Therapy: Pooled Analysis of Four NRG Oncology Radiation Therapy Oncology Group Randomized Clinical TrialsChristopher L Hallemeier, Peixin Zhang, Thomas M Pisansky, et al.
Pageof 29

Showing results (231-240 of 284) with videos related to

Sort By:
Pageof 29
International Journal of Radiation Oncology, Biology, Physics|November 6, 2021
Salvage Low-Dose-Rate Prostate Brachytherapy: Clinical Outcomes of a Phase 2 Trial for Local Recurrence after External Beam Radiation Therapy (NRG Oncology/RTOG 0526)Juanita Crook, Joseph P Rodgers, Thomas M Pisansky, et al.
The Journal of Urology|November 12, 2003
Third international conference on innovations and challenges in prostate cancer: prevention, detection and treatmentPeter R Carroll, David A Benaron, George Blackledge, et al.
Neuro-Oncology Practice|December 14, 2019
The association between BMI and BSA-temozolomide-induced myelosuppression toxicities: a correlative analysis of NRG oncology RTOG 0525H Ian Robins, Jens Eickhoff, Mark R Gilbert, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 14, 2018
The American Brachytherapy Society and the American Radium Society Appropriate Use Criteria Genitourinary Committee Endorse the American Society of Clinical Oncology/Cancer Care Ontario GuidelinesAlbert J Chang, Sean McBride, Mira Keyes, et al.
World Journal of Urology|July 10, 2020
Clinical recommendations in the management of advanced prostate cancer: International Gastrointestinal, Liver and Uro-oncology (IGILUC 2019) expertsHesham Elghazaly, Nicolas Mottet, Jorge Garcia, et al.
Cancers|June 26, 2026
A Multimodal Artificial Intelligence Model to Guide Use of Whole-Pelvic Radiation Therapy in Patients with Localized Prostate Cancer: Exploratory Analysis of RTOG 9413Mutlay Sayan, Huei-Chung Huang, Erin L Stewart, et al.
European Urology Oncology|March 3, 2023
Development and External Validation of a Machine Learning Model for Prediction of Lymph Node Metastasis in Patients with Prostate CancerAli Sabbagh, Samuel L Washington, Derya Tilki, et al.
International Journal of Radiation Oncology, Biology, Physics|May 3, 2017
Duration of Androgen Deprivation in Locally Advanced Prostate Cancer: Long-Term Update of NRG Oncology RTOG 9202Colleen A F Lawton, Xiaolei Lin, Gerald E Hanks, et al.
BJU International|January 14, 2012
Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study GroupPeter Grimm, Ignace Billiet, David Bostwick, et al.
International Journal of Radiation Oncology, Biology, Physics|April 9, 2019
Prostate-Specific Antigen After Neoadjuvant Androgen Suppression in Prostate Cancer Patients Receiving Short-Term Androgen Suppression and External Beam Radiation Therapy: Pooled Analysis of Four NRG Oncology Radiation Therapy Oncology Group Randomized Clinical TrialsChristopher L Hallemeier, Peixin Zhang, Thomas M Pisansky, et al.
Pageof 29